Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Daily Top 10 COVID-19 papers DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM

Influenza

Free Subscription 21.04.2020 1 Antimicrob Agents Chemother 1 Antiviral Res 1 Arch Virol 6 BMJ 1 Cell 1 J Exp Med 1 J Infect Dis 2 J Virol 1 JAMA 1 Lancet 4 Lancet Gastroenterol Hepatol 5 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 1 PLoS Comput Biol 1 PLoS Med 1 PLoS One 4 Proc Natl Acad Sci U S A 3 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. NGUYEN CT, Suzuki S, Itoh Y, Ishigaki H, et al
   Efficacy of neuraminidase inhibitors against H5N6 highly pathogenic avian influenza virus in a non-human primate model.
   Antimicrob Agents Chemother. 2020 Apr 13. pii: AAC.02561.
   PubMed         Abstract available
   
   

   
   Antiviral Res

2. LAURE M, Hamza H, Koch-Heier J, Quernheim M, et al
   Antiviral efficacy against Influenza virus and pharmacokinetic analysis of a novel MEK-inhibitor, ATR-002, in cell culture and in the mouse model.
   Antiviral Res. 2020 Apr 15:104806. doi: 10.1016/j.antiviral.2020.104806.
   PubMed         Abstract available
   
   

   
   Arch Virol

3. YEHIA N, Hassan WMM, Sedeek A, Elhusseiny MH, et al
   Genetic variability of avian influenza virus subtype H5N8 in Egypt in 2017 and 2018.
   Arch Virol. 2020 Apr 13. pii: 10.1007/s00705-020-04621.
   PubMed         Abstract available
   
   

   
   BMJ

4. BEECHING NJ, Fletcher TE, Beadsworth MBJ
   Covid-19: testing times.
   BMJ. 2020;369:m1403.
   PubMed        
   
   
5. FERNER RE, Aronson JK
   Chloroquine and hydroxychloroquine in covid-19.
   BMJ. 2020;369:m1432.
   PubMed        
   
   
6. GREENHALGH T, Schmid MB, Czypionka T, Bassler D, et al
   Face masks for the public during the covid-19 crisis.
   BMJ. 2020;369:m1435.
   PubMed        
   
   
7. JAVID B, Weekes MP, Matheson NJ
   Covid-19: should the public wear face masks?
   BMJ. 2020;369:m1442.
   PubMed        
   
   
8. POLLOCK AM, Clements L, Harding-Edgar L
   Covid-19: why we need a national health and social care service.
   BMJ. 2020;369:m1465.
   PubMed        
   
   
9. SPERRIN M, Grant SW, Peek N
   Prediction models for diagnosis and prognosis in Covid-19.
   BMJ. 2020;369:m1464.
   PubMed        
   
   

   
   Cell

10. WANDZIK JM, Kouba T, Karuppasamy M, Pflug A, et al
    A Structure-Based Model for the Complete Transcription Cycle of Influenza Polymerase.
    Cell. 2020 Apr 16. pii: S0092-8674(20)30389-5. doi: 10.1016/j.cell.2020.
    PubMed         Abstract available
    
    

    
    J Exp Med

11. PROKUNINA-OLSSON L, Alphonse N, Dickenson RE, Durbin JE, et al
    COVID-19 and emerging viral infections: The case for interferon lambda.
    J Exp Med. 2020;217.
    PubMed         Abstract available
    
    

    
    J Infect Dis

12. ACKERSON B, An J, Sy LS, Solano Z, et al
    Cost of Hospitalization Associated with Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    J Infect Dis. 2020 Apr 17. pii: 5821154. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

13. WALKER AP, Sharps J, Fodor E
    Mutation of an influenza virus polymerase 3' RNA promoter binding site inhibits transcription elongation.
    J Virol. 2020 Apr 15. pii: JVI.00498-20. doi: 10.1128/JVI.00498.
    PubMed         Abstract available
    
    
14. WIGNALL-FLEMING EB, Vasou A, Young D, Short JAL, et al
    Innate intracellular antiviral responses restrict the amplification of defective virus genomes of Parainfluenza Virus type 5.
    J Virol. 2020 Apr 15. pii: JVI.00246-20. doi: 10.1128/JVI.00246.
    PubMed         Abstract available
    
    

    
    JAMA

15. 
    The Prevailing Pandemic of Influenza.
    JAMA. 2020;323:1414-1415.
    PubMed        
    
    

    
    Lancet

16. MEMISH ZA, Ahmed QA, Schlagenhauf P, Doumbia S, et al
    No time for dilemma: mass gatherings must be suspended.
    Lancet. 2020;395:1191-1192.
    PubMed        
    
    

    
    Lancet Gastroenterol Hepatol

17. WU Y, Guo C, Tang L, Hong Z, et al
    Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.
    Lancet Gastroenterol Hepatol. 2020 Mar 19. pii: S2468-1253(20)30083.
    PubMed        
    
    
18. ZHANG C, Shi L, Wang FS
    Liver injury in COVID-19: management and challenges.
    Lancet Gastroenterol Hepatol. 2020 Mar 4. pii: S2468-1253(20)30057.
    PubMed        
    
    
19. MAO R, Liang J, Shen J, Ghosh S, et al
    Implications of COVID-19 for patients with pre-existing digestive diseases.
    Lancet Gastroenterol Hepatol. 2020 Mar 11. pii: S2468-1253(20)30076.
    PubMed        
    
    
20. IANIRO G, Mullish BH, Kelly CR, Sokol H, et al
    Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel.
    Lancet Gastroenterol Hepatol. 2020 Mar 16. pii: S2468-1253(20)30082.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

21. LASRY A, Kidder D, Hast M, Poovey J, et al
    Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:451-457.
    PubMed         Abstract available
    
    
22. GHINAI I, Woods S, Ritger KA, McPherson TD, et al
    Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:446-450.
    PubMed         Abstract available
    
    
23. 
    Characteristics of Health Care Personnel with COVID-19 - United States, February 12-April 9, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:477-481.
    PubMed         Abstract available
    
    
24. HEINZERLING A, Stuckey MJ, Scheuer T, Xu K, et al
    Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient - Solano County, California, February 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:472-476.
    PubMed         Abstract available
    
    
25. 
    Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:465-471.
    PubMed         Abstract available
    
    

    
    N Engl J Med

26. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Emerging Tools in the Fight against Covid-19.
    N Engl J Med. 2020;382:e39.
    PubMed        
    
    
27. PARMET WE, Sinha MS
    Covid-19 - The Law and Limits of Quarantine.
    N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMp2004211.
    PubMed        
    
    
28. NG OT, Marimuthu K, Chia PY, Koh V, et al
    SARS-CoV-2 Infection among Travelers Returning from Wuhan, China.
    N Engl J Med. 2020 Mar 12. doi: 10.1056/NEJMc2003100.
    PubMed        
    
    

    
    PLoS Comput Biol

29. QUIROUETTE C, Younis NP, Reddy MB, Beauchemin CAA, et al
    A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract.
    PLoS Comput Biol. 2020;16:e1007705.
    PubMed         Abstract available
    
    

    
    PLoS Med

30. SHEARER FM, Moss R, McVernon J, Ross JV, et al
    Infectious disease pandemic planning and response: Incorporating decision analysis.
    PLoS Med. 2020;17:e1003018.
    PubMed         Abstract available
    
    

    
    PLoS One

31. MOA AM, Muscatello DJ, Turner RM, MacIntyre CR, et al
    Estimated hospitalisations attributable to seasonal and pandemic influenza in Australia: 2001- 2013.
    PLoS One. 2020;15:e0230705.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

32. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
    Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
    Proc Natl Acad Sci U S A. 2020;117:1119-1128.
    PubMed         Abstract available
    
    
33. MATSUYAMA S, Nao N, Shirato K, Kawase M, et al
    Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
    Proc Natl Acad Sci U S A. 2020;117:7001-7003.
    PubMed         Abstract available
    
    
34. WELLS CR, Sah P, Moghadas SM, Pandey A, et al
    Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.
    Proc Natl Acad Sci U S A. 2020;117:7504-7509.
    PubMed         Abstract available
    
    
35. YEH YT, Gulino K, Zhang Y, Sabestien A, et al
    A rapid and label-free platform for virus capture and identification from clinical samples.
    Proc Natl Acad Sci U S A. 2020;117:895-901.
    PubMed         Abstract available
    
    

    
    Vaccine

36. CROSS JW, Joy M, McGee C, Akinyemi O, et al
    Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018).
    Vaccine. 2020 Apr 13. pii: S0264-410X(20)30402.
    PubMed         Abstract available
    
    
37. STAPLETON JT, Wagner N, Tuetken R, Bellamy AR, et al
    High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.
    Vaccine. 2020 Apr 12. pii: S0264-410X(20)30459.
    PubMed         Abstract available
    
    
38. CHANG CY, Cho CY, Lai CC, Lu CY, et al
    Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in healthy subjects aged 3 to 17 years old: A phase III, open label, single-arm study.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30437.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: